Evommune, Inc.
EVMN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002044725
In the last 90 days, Evommune, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $462.5M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Evommune, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- +59 vs. Q3 2025
- Shares held
- 27.2M
- +27.2M vs. Q3 2025
- Total value
- $465.7M
- +$465.7M vs. Q3 2025
- New holders
- 59
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVMN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $462.5M |
| Q1 2026 | 84 | $793.4M |
| Q4 2025 | 59 | $465.7M |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Evommune, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 4,929,633 | $84.4M | 7.59% | +4,929,633 | New |
| Ra Capital Management, L.P. | 3,458,770 | $59.2M | 0.61% | +3,458,770 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,926,943 | $33.0M | 12.75% | +1,926,943 | New |
| Andera Partners | 1,897,362 | $32.5M | 18.39% | +1,897,362 | New |
| Nan Fung Group Holdings Ltd | 1,441,032 | $24.7M | 22.08% | +1,441,032 | New |
| JPMorgan Chase & Co | 1,308,901 | $22.4M | 0.00% | +1,308,901 | New |
| RTW Investments, LP | 1,283,671 | $22.0M | 0.22% | +1,283,671 | New |
| SymBiosis Capital Partners, LLC | 1,280,778 | $21.9M | 20.03% | +1,280,778 | New |
| Marshall Wace, LLP | 988,200 | $16.9M | 0.02% | +988,200 | New |
| Eventide Asset Management, LLC | 961,525 | $16.5M | 0.26% | +961,525 | New |
| Price T Rowe Associates Inc | 782,121 | $13.4M | 0.00% | +782,121 | New |
| Sectoral Asset Management Inc | 589,005 | $10.1M | 8.08% | +589,005 | New |
| Verition Fund Management LLC | 565,214 | $9.68M | 0.05% | +565,214 | New |
| Standard Life Aberdeen plc | 525,376 | $8.99M | 0.01% | +525,376 | New |
| Velan Capital Investment Management LP | 506,754 | $8.68M | 5.05% | +506,754 | New |
| Vanguard Group Inc | 502,574 | $8.60M | 0.00% | +502,574 | New |
| Octagon Capital Advisors LP | 500,000 | $8.56M | 1.07% | +500,000 | New |
| American Century Companies Inc | 417,455 | $7.15M | 0.00% | +417,455 | New |
| Federated Hermes, Inc. | 325,000 | $5.56M | 0.01% | +325,000 | New |
| Great Point Partners LLC | 325,000 | $5.56M | 1.80% | +325,000 | New |
| NEXTBio Capital Management LP | 228,286 | $3.91M | 2.29% | +228,286 | New |
| Defilade Capital Management, L.P. | 215,418 | $3.69M | 0.50% | +215,418 | New |
| Kynam Capital Management, LP | 185,482 | $3.18M | 0.21% | +185,482 | New |
| ADAR1 Capital Management, LLC | 184,062 | $3.15M | 0.24% | +184,062 | New |
| Monashee Investment Management LLC | 183,239 | $3.14M | 1.77% | +183,239 | New |
| Sphera Funds Management Ltd. | 166,147 | $2.84M | 0.59% | +166,147 | New |
| Sofinnova Investments, Inc. | 153,320 | $2.62M | 0.11% | +153,320 | New |
| BlackRock, Inc. | 142,440 | $2.44M | 0.00% | +142,440 | New |
| Integral Health Asset Management, LLC | 125,000 | $2.14M | 0.11% | +125,000 | New |
| MPM Oncology Impact Management LP | 113,022 | $1.93M | 0.22% | +113,022 | New |
| Geode Capital Management, LLC | 109,781 | $1.88M | 0.00% | +109,781 | New |
| Ameriprise Financial Inc | 104,555 | $1.79M | 0.00% | +104,555 | New |
| Seven Grand Managers, LLC | 75,000 | $1.28M | 0.10% | +75,000 | New |
| StemPoint Capital LP | 68,196 | $1.17M | 0.20% | +68,196 | New |
| Balyasny Asset Management LLC | 65,000 | $1.11M | 0.00% | +65,000 | New |
| Charles Schwab Investment Management Inc | 62,704 | $1.07M | 0.00% | +62,704 | New |
| Goldman Sachs Group Inc | 61,675 | $1.06M | 0.00% | +61,675 | New |
| Capricorn Fund Managers Ltd | 60,000 | $1.03M | 0.25% | +60,000 | New |
| Citadel Advisors LLC | 50,560 | $865.6K | 0.00% | +50,560 | New |
| Burkehill Global Management, LP | 50,000 | $856.0K | 0.06% | +50,000 | New |
| TD Asset Management Inc | 44,634 | $764.1K | 0.00% | +44,634 | New |
| Point72 Asset Management, L.P. | 34,384 | $588.7K | 0.00% | +34,384 | New |
| Tudor Investment Corp Et Al | 31,953 | $547.0K | 0.00% | +31,953 | New |
| State Street Corp | 31,500 | $539.3K | 0.00% | +31,500 | New |
| Qube Research & Technologies Ltd | 24,057 | $411.9K | 0.00% | +24,057 | New |
| Northern Trust Corp | 22,636 | $387.5K | 0.00% | +22,636 | New |
| Two Sigma Investments, LP | 21,324 | $365.1K | 0.00% | +21,324 | New |
| Oxford Asset Management LLP | 19,565 | $335.0K | 0.12% | +19,565 | New |
| XTX Topco Ltd | 18,778 | $321.5K | 0.01% | +18,778 | New |
| Manufacturers Life Insurance Company, The | 10,225 | $179.1K | 0.00% | +10,225 | New |
| Morgan Stanley | 8,346 | $142.9K | 0.00% | +8,346 | New |
| UBS Group AG | 3,414 | $58.4K | 0.00% | +3,414 | New |
| Bank of America Corp | 2,937 | $50.3K | 0.00% | +2,937 | New |
| Tower Research Capital LLC (TRC) | 2,745 | $47.0K | 0.00% | +2,745 | New |
| National Bank of Canada | 2,200 | $37.5K | 0.00% | +2,200 | New |
| China Universal Asset Management Co., Ltd. | 2,000 | $34.2K | 0.00% | +2,000 | New |
| Royal Bank of Canada | 585 | $10.0K | 0.00% | +585 | New |
| Legal & General Group Plc | 400 | $6.85K | 0.00% | +400 | New |
| Comerica Bank | 20 | $330 | 0.00% | +20 | New |